Clinical evaluation of the bispecific antibody MDX-H210 (anti-FcgammaRIx anti-HER-2/neu) in combination with G-CSF (Filgrastim) for treatment of advanced breast cancer

H.H. van Ojik; R. Repp; G. Groenewegen; T. Valerius; J.G.J. van de Winkel

Clinical evaluation of the bispecific antibody MDX-H210 (anti-FcgammaRIx anti-HER-2/neu) in combination with G-CSF (Filgrastim) for treatment of advanced breast cancer

H.H. van Ojik, R. Repp, G. Groenewegen, T. Valerius, J.G.J. van de Winkel

Utrecht University

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	207-209
Number of pages	3
Journal	Cancer Immunology, Immunotherapy
Volume	45
Publication status	Published - 1997

Cite this

@article{9b4ad76c3a9042e693e0aec1aea4af40,

title = "Clinical evaluation of the bispecific antibody MDX-H210 (anti-FcgammaRIx anti-HER-2/neu) in combination with G-CSF (Filgrastim) for treatment of advanced breast cancer",

author = "{van Ojik}, H.H. and R. Repp and G. Groenewegen and T. Valerius and {van de Winkel}, J.G.J.",

year = "1997",

language = "Undefined/Unknown",

volume = "45",

pages = "207--209",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Clinical evaluation of the bispecific antibody MDX-H210 (anti-FcgammaRIx anti-HER-2/neu) in combination with G-CSF (Filgrastim) for treatment of advanced breast cancer

AU - van Ojik, H.H.

AU - Repp, R.

AU - Groenewegen, G.

AU - Valerius, T.

AU - van de Winkel, J.G.J.

PY - 1997

Y1 - 1997

M3 - Article

SN - 0340-7004

VL - 45

SP - 207

EP - 209

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

ER -